2010 Radiation Oncology Mentors & Projects
| Projects |
Research Area |
Preceptor |
| Preclinical evaluation of Rad50 inhibitors as radiosensitizers |
Radiobiology |
Alan Tomkinson, PhD |
| Chemopotentiation of low-dose fractionated radiation therapy in lymphomas |
Radiobiology |
France Carrier, PhD |
| Radiosensitizing effect of Histone Deacetylase Inhibitors for the treatment of GBM with LDFRT in combination with RT |
Radiobiology |
France Carrier, PhD |
| Participate in critical evaluation of the cancer elimination properties of DNA ligase inhibitors in the process of drug discovery and novel cancer therapeutic development |
Radiobiology |
Helen Xi Chen, PhD
|
| Elucidate the molecular mechanism of human RS (radiosensitive)-SCID (severe combined immunodeficiency) syndrome and the pathways that suppress the symptoms |
Radiobiology |
Helen Xi Chen, PhD
|
| Therapeutic strategies in chronic myeloid leukemia with resistance to tyrosine kinase inhibitors use of PARP and DNA ligase inhibitors |
Radiobiology |
Fey Rassool, PhD |
| Mechanism(s) for DNA damage caused by chromatin modifying agents, such as histone deacetylase inhibitors in myeloid malignancies |
Radiobiology |
Fey Rassool, PhD |
| Mechanism(s) for genomic instability in AML with FLT3/ITD mutations |
Radiobiology |
Fey Rassool, PhD |
| DNA damage and repair capacity as mechanism(s) for genomic instability in hematopoietic stem cells, leukemic stem cells and embryonic stem cells |
Radiobiology |
Fey Rassool, PhD |
| Preclinical evaluation of DNA ligase inhibitors as novel anti cancer agents |
Radiobiology |
Alan Tomkinson, PhD |
| University of Maryland experience with GKRS for radio-resistant histologies +/- whole brain radiotherapy |
Clinical |
William Regine, MD / Young Kwok, MD |
| Preclinical evaluation of PARP inhibitors as low-dose radiation sensitizers in brain cancer |
Radiobiology
|
Elizabeth Kubiczek, PhD
|
| 4D Treatment Planning |
Physics |
Warren D'Souza, PhD |
